🟢 Marker Therapeutics is trading 10.4% up today with biotech ETF XBI up 2.18%

Marker Therapeutics is trading at $1.05, up 10.38%, with no company-specific announcement identified for October 28.

• The latest reported company news was an FDA grant announced October 19.
• Biotech ETF XBI is up 2.18%, a possible sector tailwind that does not establish the cause of the stock’s larger gain.
• Major U.S. indexes are little changed, so broad-market gains do not clearly explain the move.